Today, ASH announced the names of 15 investigators who have been awarded $150,000 through the ASH Bridge Grant Program, supporting promising hematology research proposals that score well but cannot be funded by the National Institutes of Health (NIH) because of budget uncertainty.

ASH announced a partnership with the University of North Carolina at Chapel Hill, a National Institutes of Health Clinical Genome Resource grantee, to develop a broad and accessible compendium of genomic data aimed at improving the diagnosis of some blood cancers and disorders.

A statement by ASH’s president on the FY2018 omnibus funding package that was signed into law today by President Trump. This bill includes $37.1 billion for the NIH, a nearly 9% increase for the agency.

CMS released a National Coverage Determination entitled Next Generation Sequencing for Medicare Beneficiaries with Advanced Cancer. ASH submitted comments on the proposal along with over 300 other groups, including physician specialty societies, patient advocacy groups, and industry groups.

On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.

Congress spent much of 2017 focused on the repeal and replace of the Affordable Care Act (ACA). Included is a summary of Congress and the Administration’s actions on repeal and replace of the ACA that occurred in 2017.

Dr. Michaelis introduces a new department, "Off the Shelf," which will allow readers to reflect on their calling and recommend or discuss literature that has changed the way they approach their day-to-day work.

The ASH Summit on Emerging Immunotherapies for Hematologic Diseases program co-chairs Drs. Catherine Bollard, Rodrigo Calado, Sergio Giralt, and Jeffrey Miller share their thoughts on what to anticipate at the meeting.